Integrated Core Strategies (US) LLC 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 4:28 pm Sale |
2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
Integrated Core Strategies (US) LLC | 286,632 0.200% |
-9,688,845 (-97.13%) |
Filing |